Can a robot make hysterectomy safer and more precise?
NCT ID NCT07746531
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study looks at how well the DEXTER robotic surgery system performs during hysterectomy (removal of the uterus) for non-cancerous conditions. It will track 112 adults to see if the procedure is completed successfully without needing to switch to another surgical method, and to monitor for any serious complications. The goal is to gather real-world evidence on the device's safety and effectiveness in routine practice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- DEXTER robotic surgery system
- What this could lead to
- If successful, this could support the safe and effective use of robotic-assisted surgery for hysterectomy, potentially offering a less invasive option with precise control.
- What could go wrong
- As an observational post-market study, it does not compare against other techniques, and results may not apply to all patients. Risks include surgical complications inherent to hysterectomy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 112 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients undergoing a hysterectomy for benign disease
- Ages
-
22 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient is ≥ 22 years of age at time of enrollment/consent * Patient is planned to undergo robotic-assisted and laparoscopic hysterectomy for benign disease * Patient agrees to perform the 6-week follow-up assessment as per standard of care Exclusion Criteria: * Any planned concomitant procedures (not including salpingectomy and/or oophorectomy) * Diagnosed malignant disease on reproductive organs * Uterus myomatous with fibroid \> 10cm
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hysterectomy, benign uterine diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cypress surgery center
Wichita, Kansas, 67226, United States
-
Memorial Hermann-Texas Medical Center - UT Health Houston
Houston, Texas, 77030-1501, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.